THE STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAR RNA REVEALS PRINCIPLES OF RNA RECOGNITION BY TAT PROTEIN

被引:362
|
作者
ABOULELA, F [1 ]
KARN, J [1 ]
VARANI, G [1 ]
机构
[1] MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND
基金
英国医学研究理事会;
关键词
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; TAT; TAR RNA STRUCTURE; RNA-PROTEIN RECOGNITION; HETERONUCLEAR NMR OF RNA;
D O I
10.1006/jmbi.1995.0555
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcriptional elongation. Tat is introduced to the transcription machinery by binding to the transactivation response region (TAR) RNA stem-loop encoded by the 5' leader sequence found on all HIV-1 mRNAs. We have used multidimensional heteronuclear NMR to determine the structure of the TAR RNA in the presence of the ADP-1 polypeptide, a 37-mer that carries the minimal RNA recognition region of the Tat protein and closely mimics Tat binding specificity In the presence of a variety of ligands, including ADP-1, related basic peptides and the amino acid derivative argininamide, the bulge region of TAR undergoes a local conformational rearrangement and forms a more stable structure. The structure of TAR in the bound form has been determined from over 1000 NMR-derived constraints. The U23 residue at the 5' end of the bulge is positioned near G26 and A27 in the major groove, rather than stacked on A22 as in the free TAR. U23 and G26 are brought into close proximity by contacts to the guanidinium group and side-chain amide group of a common arginine residue. However, the interaction of this guanidinium group with TAR is not the only source of binding specificity Besides NOEs to the arginine residue participating in the conformational change, ADP-1 shows additional intermolecular NOEs to TAR, suggesting that there are multiple points of contacts between TAR RNA and residues from the basic and core regions of Tat. These structural results provide important clues towards the identification of small molecular mass and/or peptidomimetic inhibitors of the essential Tat-TAR interaction. (C) 1995 Academic Press Limited
引用
收藏
页码:313 / 332
页数:20
相关论文
共 50 条
  • [41] EVIDENCE FOR NEUROTOXIC ACTIVITY OF TAT FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SABATIER, JM
    VIVES, E
    MABROUK, K
    BENJOUAD, A
    ROCHAT, H
    DUVAL, A
    HUE, B
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1991, 65 (02) : 961 - 967
  • [42] NMR SOLUTION STRUCTURE OF THE RNA-BINDING PEPTIDE FROM HUMAN-IMMUNODEFICIENCY-VIRUS (TYPE-1) REV
    SCANLON, MJ
    FAIRLIE, DP
    CRAIK, DJ
    ENGLEBRETSEN, DR
    WEST, ML
    BIOCHEMISTRY, 1995, 34 (26) : 8242 - 8249
  • [43] ELUCIDATION OF A CONSERVED RNA STEM-LOOP STRUCTURE IN THE PACKAGING SIGNAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HAYASHI, T
    UENO, Y
    OKAMOTO, T
    FEBS LETTERS, 1993, 327 (02) : 213 - 218
  • [44] TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS A MONOMER WHEN EXPRESSED IN MAMMALIAN-CELLS
    RICE, AP
    CHAN, F
    VIROLOGY, 1991, 185 (01) : 451 - 454
  • [45] CHANGES IN CELLULAR PROTEINS ASSOCIATED WITH THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATOR PROTEIN TAT
    RANGANATHAN, PN
    RANGANATHAN, S
    SRINIVASAN, A
    DNA AND CELL BIOLOGY, 1993, 12 (09) : 831 - 837
  • [46] DETECTION AND QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 USING MOLECULAR DNA/RNA TECHNOLOGY
    JACKSON, JB
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1993, 117 (05) : 473 - 477
  • [47] IDENTIFICATION OF THE PRIMARY SITE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA DIMERIZATION IN-VITRO
    SKRIPKIN, E
    PAILLART, JC
    MARQUET, R
    EHRESMANN, B
    EHRESMANN, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4945 - 4949
  • [48] CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING
    KAYE, JF
    RICHARDSON, JH
    LEVER, AML
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6588 - 6592
  • [49] CHARACTERIZATION AND EXPRESSION OF NOVEL SINGLY SPLICED RNA SPECIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ARRIGO, SJ
    WEITSMAN, S
    ZACK, JA
    CHEN, ISY
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4585 - 4588
  • [50] EFFECTS OF THE TAT BASIC DOMAIN ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATION, USING CHEMICALLY SYNTHESIZED TAT PROTEIN AND TAT PEPTIDES
    VIVES, E
    CHARNEAU, P
    VANRIETSCHOTEN, J
    ROCHAT, H
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3343 - 3353